Pomerantz LLP Investigates Claims of Securities Fraud Against Neogen Corporation
Pomerantz LLP is conducting an investigation into potential securities fraud allegations against Neogen Corporation, following the company's disclosure of fourth-quarter fiscal 2025 financial results. The investigation centers around whether Neogen and its senior executives engaged in unlawful business practices or securities fraud. The news led to a significant decline in Neogen's stock price, falling $1.04 per share, or 17.3%, on June 4, 2025.
Key Takeaways:
- The investigation is focused on potential securities fraud and unlawful business practices by Neogen and its senior executives.
- Neogen's fourth-quarter fiscal 2025 financial results were revealed on June 4, 2025, showing a decline in earnings before interest, taxes, depreciation, and amortization (EBITDA) margin to around the high-teens, compared to 22% in the previous quarter.
- Elevated inventory write-offs were cited as the reason for the decline in EBITDA margin.
- Neogen's stock price dropped $1.04 per share, or 17.3%, to close at $4.96 per share on June 4, 2025.
- Pomerantz LLP is a veteran class-action law firm with a history of securing multimillion-dollar damages awards on behalf of class members.
- The firm has offices in New York, Chicago, Los Angeles, London, and Paris and has pioneered the field of securities class actions.
Statistics:
- Neogen's stock price fell $1.04 per share, or 17.3%, on June 4, 2025.
- The drop in EBITDA margin was attributed to elevated inventory write-offs.
- Pomerantz LLP has recovered numerous multimillion-dollar damages awards on behalf of class members.
- The firm has a history of securing significant compensation for victims of securities fraud.
- The investigation is ongoing, with Pomerantz LLP representing investors' interests.
Sources:
- Pomerantz LLP
- PRNewswire
- Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980
- Pomerantz LLP's website for information on the firm's history and expertise in class-action law.